Intestinal translocation of clinical isolates of vancomycin-resistant Enterococcus faecalis and ESBL-producing Escherichia coli in a rat model of bacterial colonization and liver ischemia/reperfusion injury
- PMID: 25255079
- PMCID: PMC4177999
- DOI: 10.1371/journal.pone.0108453
Intestinal translocation of clinical isolates of vancomycin-resistant Enterococcus faecalis and ESBL-producing Escherichia coli in a rat model of bacterial colonization and liver ischemia/reperfusion injury
Abstract
The objectives of this study were to develop a rat model of gastrointestinal colonization with vancomycin-resistant Enterococcus faecalis (VRE) and extended-spectrum beta-lactamase (ESBL)-producing E. coli and to evaluate intestinal translocation to blood and tissues after total and partial hepatic ischemia. Methods - We developed a model of rat colonization with VRE and ESBL-E coli. Then we studied four groups of colonized rats: Group I (with hepatic pedicle occlusion causing complete liver ischemia and intestinal stasis); Group II (with partial liver ischemia without intestinal stasis); Group III (surgical manipulation without hepatic ischemia or intestinal stasis); Group IV (anesthetized without surgical manipulation). After sacrifice, portal and systemic blood, large intestine, small intestine, spleen, liver, lungs, and cervical and mesenteric lymph nodes were cultured. Endotoxin concentrations in portal and systemic blood were determined. Results - The best inocula were: VRE: 2.4×10(10) cfu and ESBL-E. coli: 1.12×10(10) cfu. The best results occurred 24 hours after inoculation and antibiotic doses of 750 µg/mL of water for vancomycin and 2.1 mg/mL for ceftriaxone. There was a significantly higher proportion of positive cultures for ESBL-E. coli in the lungs in Groups I, II and III when compared with Group IV (67%; 60%; 75% and 13%, respectively; p:0.04). VRE growth was more frequent in mesenteric lymph nodes for Groups I (67%) and III (38%) than for Groups II (13%) and IV (none) (p:0.002). LPS was significantly higher in systemic blood of Group I (9.761 ± 13.804 EU/mL-p:0.01). No differences for endotoxin occurred in portal blood. Conclusion -We developed a model of rats colonized with resistant bacteria useful to study intestinal translocation. Translocation occurred in surgical procedures with and without hepatic ischemia-reperfusion and probably occurred via the bloodstream. Translocation was probably lymphatic in the ischemia-reperfusion groups. Systemic blood endotoxin levels were higher in the group with complete hepatic ischemia.
Conflict of interest statement
Similar articles
-
Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice.J Med Microbiol. 2001 Aug;50(8):695-701. doi: 10.1099/0022-1317-50-8-695. J Med Microbiol. 2001. PMID: 11478673
-
[Effect of chloroquine on the apoptosis of intestinal mucosa epithelial cells and enterogenous bacteria-endotoxin translocation after total hepatic ischemia-reperfusion in rats].Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Apr;31(2):245-8. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006. PMID: 16706125 Chinese.
-
Angiotensin II inhibitor DuP753 attenuates burn- and endotoxin-induced gut ischemia, lipid peroxidation, mucosal permeability, and bacterial translocation.Ann Surg. 2000 Apr;231(4):566-76. doi: 10.1097/00000658-200004000-00017. Ann Surg. 2000. PMID: 10749619 Free PMC article.
-
Treatment options for vancomycin-resistant enterococcal infections.Drugs. 2002;62(3):425-41. doi: 10.2165/00003495-200262030-00002. Drugs. 2002. PMID: 11827558 Review.
-
Screening, Isolation, and Decolonization Strategies for Vancomycin-Resistant Enterococci or Extended Spectrum Beta-Lactamase Producing Organisms: A Systematic Review of the Clinical Evidence and Health Services Impact [Internet].Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2012 Sep. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2012 Sep. PMID: 24354039 Free Books & Documents. Review.
Cited by
-
New Insights into the Enterococcus faecium and Streptococcus gallolyticus subsp. gallolyticus Host Interaction Mechanisms.PLoS One. 2016 Jul 27;11(7):e0159159. doi: 10.1371/journal.pone.0159159. eCollection 2016. PLoS One. 2016. PMID: 27463203 Free PMC article.
-
Exopolysaccharide-mediated surface penetration as new virulence trait in Enterococcus faecalis.Commun Integr Biol. 2019 Aug 26;12(1):144-147. doi: 10.1080/19420889.2019.1657373. eCollection 2019. Commun Integr Biol. 2019. PMID: 31666914 Free PMC article.
-
Use of molecular typing to investigate bacterial translocation from the intestinal tract of chlorpyrifos-exposed rats.Gut Pathog. 2016 Nov 5;8:50. doi: 10.1186/s13099-016-0129-x. eCollection 2016. Gut Pathog. 2016. PMID: 27826358 Free PMC article.
-
The effect of different treatments of lymph after intestinal ischemia-reperfusion in rats on macrophages in vitro.PLoS One. 2019 Jan 25;14(1):e0211195. doi: 10.1371/journal.pone.0211195. eCollection 2019. PLoS One. 2019. PMID: 30682177 Free PMC article.
-
[Development of animal experimental model for bacterial peritonitis].Rev Esp Quimioter. 2020 Feb;33(1):18-23. doi: 10.37201/req/064.2019. Epub 2019 Dec 3. Rev Esp Quimioter. 2020. PMID: 31795629 Free PMC article. Spanish.
References
-
- Baumgart DC, Dignass AU (2002) Intestinal Barrier Function. Curr Opin Clin Nutr Metab Care 5: 685–694. - PubMed
-
- Swank GM, Deitch EA (1996) Role of gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 20: 411–417. - PubMed
-
- Camilleri M, Lasch K, Zhou W (2012) Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 303: G775–785 doi:10.1152/ajpgi.00155.2012 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources